In this paper we argue that there is an extensive number of studies examining how firms obtain new products from their interactions with scientific agents, but other type of benefits has been overlooked. Specifically, we add to previous literature by considering not only product innovation, but also exploratory (long-term) and exploitative (short-term) results. We administer a tailored survey to firms collaborating with the Spanish National Research Council (CSIC) and data was completed with secondary sources. Results based on a sample of 756 firms suggest that firms consider all types of result as moderately important to them. Moreover, we observe that small firms report higher benefits in terms of product innovation and long-term results in contrast to large firms.

在本文中，我们认为，有大量研究检查了企业如何从与科学代理人的互动中获得新产品，但是其他类型的收益却被忽略了。具体而言，我们不仅考虑产品创新，还考虑探索性（长期）和开发性（短期）结果，从而增加了以前的文献。我们对与西班牙国家研究委员会（CSIC）合作的公司进行量身定制的调查，并通过辅助来源完成了数据。根据756家公司的样本得出的结果表明，公司认为所有类型的结果对他们都具有中等重要性。此外，我们观察到，与大公司相比，小公司在产品创新和长期结果方面报告了更高的收益。